IHC image of CSB-PA017647LA01HU diluted at 1:500 and staining in paraffin-embedded human colon cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
IHC image of CSB-PA017647LA01HU diluted at 1:500 and staining in paraffin-embedded human colon cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
PCSK9 Antibody
CSB-PA017647LA01HU
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoHistoChemistry
Product group Antibodies
TargetPCSK9
Overview
- SupplierCusabio
- Product NamePCSK9 Antibody
- Delivery Days Customer20
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID255738
- Target namePCSK9
- Target descriptionproprotein convertase subtilisin/kexin type 9
- Target synonymsconvertase subtilisin/kexin type 9 preproprotein; FH3; FHCL3; HCHOLA3; LDLCQ1; NARC1; NARC-1; neural apoptosis regulated convertase 1; PC9; proprotein convertase subtilisin/kexin type 9; subtilisin/kexin-like protease PC9
- HostRabbit
- IsotypeIgG
- Protein IDQ8NBP7
- Protein NameProprotein convertase subtilisin/kexin type 9
- Scientific DescriptionCrucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments (PubMed:18039658). Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation (PubMed:18799458, PubMed:17461796, PubMed:18197702, PubMed:22074827). Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway (PubMed:18660751). Inhibits epithelial Na(+) channel (ENaC)-mediated Na(+) absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways.
- Storage Instruction-20°C or -80°C
- UNSPSC12352203
Related products
Product group Antibodies
Goat anti-PCSK9 (C Terminus)EB06682
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry
TargetPCSK9
- SizePrice
Product group Antibodies
Pcsk9 Polyclonal AntibodyCAC11631
ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
TargetPCSK9
- SizePrice
Product group Antibodies
References
PCSK9 antibodyGTX129859
ApplicationsFlow Cytometry, Western Blot, ELISA
TargetPCSK9
- SizePrice
Product group Antibodies
ApplicationsImmunoPrecipitation
TargetPCSK9
- SizePrice
Product group Antibodies
Anti-PCSK9 Antibody144-07860
ApplicationsWestern Blot, ImmunoHistoChemistry
TargetPCSK9
- SizePrice
Product group Antibodies
Anti-PCSK9 AntibodyA15935
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry
- SizePrice
Product group Antibodies
ApplicationsWestern Blot, ELISA, Neutralisation/Blocking
TargetPCSK9
- SizePrice